These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 7016266)
1. Metabolism of NG-monomethyl-L-arginine: formation of NG-methylagmatine by Escherichia coli preparation. Paik WK; Kim S; Hutchins MG; Swern D Can J Biochem; 1981 Feb; 59(2):131-6. PubMed ID: 7016266 [No Abstract] [Full Text] [Related]
2. Synthesis of NG-monomethylagmatine, a decarboxylation product of NG-monomethyl-L-arginine. Cho YB; Park KS; Kim S; Paik WK Anal Biochem; 1987 Feb; 160(2):429-33. PubMed ID: 3107423 [TBL] [Abstract][Full Text] [Related]
3. Control of utilization of L-arginine, L-ornithine, agmatine, and putrescine as nitrogen sources in Escherichia coli K-12. Shaibe E; Metzer E; Halpern YS J Bacteriol; 1985 Sep; 163(3):938-42. PubMed ID: 3897202 [TBL] [Abstract][Full Text] [Related]
4. Metabolism of NG-monomethyl-L-arginine. Paik WK; Abou-Gharbia M; Swern D; Lotlikar P; Kim S Can J Biochem Cell Biol; 1983 Aug; 61(8):850-5. PubMed ID: 6627096 [TBL] [Abstract][Full Text] [Related]
5. Biosynthesis of polyamines in ornithine decarboxylase, arginine decarboxylase, and agmatine ureohydrolase deletion mutants of Escherichia coli strain K-12. Panagiotidis CA; Blackburn S; Low KB; Canellakis ES Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4423-7. PubMed ID: 2440022 [TBL] [Abstract][Full Text] [Related]
6. L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. Hibbs JB; Vavrin Z; Taintor RR J Immunol; 1987 Jan; 138(2):550-65. PubMed ID: 2432129 [TBL] [Abstract][Full Text] [Related]
7. N omega-nitro-L-arginine: a potent inhibitor of endothelium-derived relaxing factor formation. Ishii K; Chang B; Kerwin JF; Huang ZJ; Murad F Eur J Pharmacol; 1990 Feb; 176(2):219-23. PubMed ID: 2155799 [TBL] [Abstract][Full Text] [Related]
8. Effects of guanidino compounds on the endothelium-derived relaxing factor inhibitor NG-monomethyl L-arginine. Thomas G; Ramwell PW J Pharmacol Exp Ther; 1991 Nov; 259(2):490-4. PubMed ID: 1719191 [TBL] [Abstract][Full Text] [Related]
9. Endothelium-dependent relaxation and L-arginine metabolism in genetic hypertension. Lee L; Webb RC Hypertension; 1992 May; 19(5):435-41. PubMed ID: 1568761 [TBL] [Abstract][Full Text] [Related]
14. L-N6-(1-iminoethyl)-lysine potently inhibits inducible nitric oxide synthase and is superior to NG-monomethyl-arginine in vitro and in vivo. Stenger S; Thuring H; Rollinghoff M; Manning P; Bogdan C Eur J Pharmacol; 1995 Dec; 294(2-3):703-12. PubMed ID: 8750736 [TBL] [Abstract][Full Text] [Related]
15. NG-monomethyl L-arginine is a non-specific inhibitor of vascular relaxation. Thomas G; Cole EA; Ramwell PW Eur J Pharmacol; 1989 Oct; 170(1-2):123-4. PubMed ID: 2612562 [No Abstract] [Full Text] [Related]
16. The effects of L-arginine and NG-monomethyl L-arginine on the inhibitory neurotransmission of the human corpus cavernosum penis. Sjöstrand NO; Eldh J; Samuelson UE; Alaranta S; Klinge E Acta Physiol Scand; 1990 Oct; 140(2):297-8. PubMed ID: 2176435 [No Abstract] [Full Text] [Related]
17. Identification of inhibitors of nitric oxide synthase that do not interact with the endothelial cell L-arginine transporter. Bogle RG; Moncada S; Pearson JD; Mann GE Br J Pharmacol; 1992 Apr; 105(4):768-70. PubMed ID: 1380372 [TBL] [Abstract][Full Text] [Related]